Home Data Calendar Blog

VIR

Tables

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.00NANA0.00NANANA
Weighted Average Number Of Diluted Shares Outstanding 134.96132.45NANA133.85133.79NANA125.81114.98NANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic 132.73132.45NANA130.67130.12NANA125.81114.98NANANANANANANANANA
Earnings Per Share Basic 1.32-0.583.934.040.850.48-1.32-0.83-0.67-0.27-0.71-0.69-4.60-16.38-14.36NANANANA
Earnings Per Share Diluted 1.30-0.583.853.940.820.46-1.32-0.83-0.67-0.27-0.71-0.71-4.60-16.38-14.36NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenues 374.56-40.631232.46812.75103.62177.071.981.731.9366.995.720.981.402.053.663.132.882.222.43
Cost Of Revenue 22.2527.9290.1556.887.841.14NANANANANANANANANANANANANA
Costs And Expenses 179.59184.59218.63241.00157.00116.05160.61NANANANANANANANANANANANA
Research And Development Expense 114.17115.0890.23128.3498.6786.13134.8787.0970.6879.6564.9852.9339.8629.8025.8721.9729.84NANA
Selling General And Administrative Expense 43.1741.5938.2655.7850.5028.7825.7423.0418.8616.39NANANANANANANANANA
Operating Income Loss 194.96-225.221013.83571.75-53.3861.02-158.63-108.40-87.61-29.05-71.91-63.76-47.68-35.77-30.77-26.80-34.35NANA
Allocated Share Based Compensation Expense 24.8127.1025.3024.3722.9421.0015.4710.308.585.752.972.682.191.402.450.951.45NANA
Income Tax Expense Benefit 42.42-157.23403.2920.640.330.050.20-0.030.020.050.020.15-0.010.02NA0.02NANANA
Income Taxes Paid Net 102.24NANANANANANANANANANANANANANANANANANA
Profit Loss 175.31-76.49518.62525.25110.4361.81-168.91-105.65-84.61-31.17-77.24-63.77-48.31-33.93-28.67-26.39NANANA
Net Income Loss 175.31-76.49518.62525.25110.4361.81-168.91-105.65-84.61-31.17-77.24-63.77-48.31-33.93-28.67-26.39-33.46-24.45-31.59
Comprehensive Income Net Of Tax 170.99-79.24514.91525.46110.4561.78-168.94-106.44-84.80-31.71-76.39-64.45-48.47-33.78-28.56-26.37-33.48NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Assets 2695.972618.992887.131954.271210.211057.581135.58918.76943.26672.24477.11512.07422.64NANA191.60NANANA
Liabilities 546.12666.98886.12522.42333.94320.26484.63201.91130.90108.4696.7888.1366.83NANA61.64NANANA
Liabilities And Stockholders Equity 2695.972618.992887.131954.271210.211057.581135.58918.76943.26672.24477.11512.07422.64NANA191.60NANANA
Stockholders Equity 2149.861952.012001.011431.85876.27737.33650.95716.85812.36563.78380.33423.94-280.80-236.97-205.22-179.18-154.02-122.30NA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Assets Current 2413.622288.272567.551562.821066.34862.29993.11772.37849.57578.76377.54403.00337.72NANA117.78NANANA
Cash And Cash Equivalents At Carrying Value 963.741505.18812.36347.81714.52741.95521.40436.57462.52371.78168.42109.3393.7080.6864.7247.6047.67NANA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 983.971526.68835.80363.42727.63755.96537.00451.49473.08384.00178.71122.82105.3793.3073.1259.3662.33NANA
Marketable Securities Current 1359.94654.11399.83217.1855.5684.11211.64300.29364.07180.60187.19274.10226.51NANA50.84NANANA
Accounts Receivable Net Current NA7.001223.16773.0893.00NA112.50NANANANANANANANANANANANA
Prepaid Expense And Other Assets Current 54.1872.4269.9173.0027.7729.2326.4827.5113.6115.3612.8313.388.69NANA8.58NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Property Plant And Equipment Gross 119.15102.5081.4957.3339.7232.0227.7927.1824.9623.2022.0721.1419.60NANA14.01NANANA
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 18.9217.3715.9014.4913.1111.7710.509.238.026.895.834.834.15NANA1.72NANANA
Amortization Of Intangible Assets 0.130.130.130.130.130.130.130.120.310.310.310.300.310.310.310.30NANANA
Property Plant And Equipment Net 100.2385.1465.5842.8326.6120.2517.2917.9516.9516.3116.2416.3115.45NANA12.29NANANA
Long Term Investments 34.1097.58103.53201.39NA50.68NANANANA6.1424.29NANANANANANANA
Intangible Assets Net Excluding Goodwill 32.8933.0233.1533.2933.4233.5533.6933.8233.9435.0835.3935.6936.00NANA36.92NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Liabilities Current 308.20477.87702.36341.24233.72146.02361.1099.0677.0054.9456.4059.2144.32NANA39.91NANANA
Accounts Payable Current 2.7210.6210.966.524.2211.033.705.086.804.3818.775.885.82NANA6.47NANANA
Other Accrued Liabilities Current 21.3917.7817.5510.255.323.331.720.540.890.590.771.251.73NANA2.66NANANA
Accrued Income Taxes Current 98.19157.54404.436.22NANANANANANANANANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Deferred Income Tax Liabilities Net 18.4418.4418.4418.443.253.253.253.253.313.31NA3.31NANANANANANANA
Other Liabilities Noncurrent 7.177.607.752.543.823.853.813.852.982.972.943.573.03NANA1.59NANANA
Operating Lease Liability Noncurrent 126.94130.21132.81133.5668.6068.9466.6166.5612.0912.7613.53NANANANANANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Stockholders Equity 2149.861952.012001.011431.85876.27737.33650.95716.85812.36563.78380.33423.94-280.80-236.97-205.22-179.18-154.02-122.30NA
Common Stock Value 0.010.010.010.010.010.010.010.010.010.010.010.010.00NANA0.00NANANA
Additional Paid In Capital 1682.881656.021625.791571.541541.421512.931488.341385.301374.361040.99825.83793.0523.87NANA14.67NANANA
Retained Earnings Accumulated Deficit 478.84303.53380.02-138.60-663.85774.28-836.10-667.18-561.53-476.93-445.76-368.52-304.75NANA-193.84NANANA
Accumulated Other Comprehensive Income Loss Net Of Tax -11.88-7.55-4.80-1.10-1.31-1.33-1.30-1.28-0.48-0.290.25-0.600.08NANA-0.01NANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value 24.8127.1025.3024.3722.9421.0015.4710.308.585.752.972.682.191.402.450.951.45NANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities 117.90960.14550.097.70-105.81140.06-89.53-82.05-49.84-10.64-48.41-38.88-36.95-24.30-29.49-29.51NANANA
Net Cash Provided By Used In Investing Activities -662.61-272.33-105.39-377.5873.8675.3887.5360.71-185.3810.59104.22-73.7747.2944.48-274.1616.10NANANA
Net Cash Provided By Used In Financing Activities 1.993.0827.685.673.633.5387.50-0.26324.31205.340.09130.101.730.00317.4110.44NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Operating Activities 117.90960.14550.097.70-105.81140.06-89.53-82.05-49.84-10.64-48.41-38.88-36.95-24.30-29.49-29.51NANANA
Net Income Loss 175.31-76.49518.62525.25110.4361.81-168.91-105.65-84.61-31.17-77.24-63.77-48.31-33.93-28.67-26.39-33.46-24.45-31.59
Profit Loss 175.31-76.49518.62525.25110.4361.81-168.91-105.65-84.61-31.17-77.24-63.77-48.31-33.93-28.67-26.39NANANA
Depreciation Depletion And Amortization 1.601.501.421.391.401.301.271.221.101.101.000.860.900.800.710.590.40NANA
Increase Decrease In Accounts Receivable -58.18-883.77450.08680.08NANANANANANANANANANANANANANANA
Increase Decrease In Accounts Payable -4.45-1.393.830.79-5.896.25-1.32-1.832.38-14.2912.940.541.26-2.001.16-1.23NANANA
Share Based Compensation 24.8127.1025.3024.3722.9421.0015.4710.308.585.752.972.682.191.402.450.95NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Investing Activities -662.61-272.33-105.39-377.5873.8675.3887.5360.71-185.3810.59104.22-73.7747.2944.48-274.1616.10NANANA
Payments To Acquire Property Plant And Equipment 18.9920.6015.8413.076.012.080.672.431.471.341.301.551.262.653.482.80NANANA
Payments To Acquire Investments 728.46251.7389.56364.510.0050.735.0040.44233.5089.4340.47147.96135.9137.19322.83NANANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Net Cash Provided By Used In Financing Activities 1.993.0827.685.673.633.5387.50-0.26324.31205.340.09130.101.730.00317.4110.44NANANA

    2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31
Revenues 374.56-40.631232.46812.75103.62177.071.981.731.9366.995.720.981.402.053.663.132.882.222.43
Two Thousand Twenty Glaxo Wellcome U K Limited And Beecham S A, Collaboration Revenue NANA1.20-106.78102.405.30NANANANANANANANANANANANANA
License 22.29NANANANANANA0.000.0022.75NANANANANANANANANA
Collaboration Revenue 309.14-54.941229.66809.46102.405.33NANANANANANANANANANANANANA
Contract Revenue 40.0012.250.280.290.32168.650.600.300.1943.520.490.370.240.090.020.010.11NANA
Brii Biosciences Offshore Limited NA1.30NANANANANANANANANANANANANANANANANA
Two Thousand Twenty Glaxo Wellcome U K Limited And Beecham S A, Amendment Number One NA7.00NANANANANANANANANANANANANANANANANA

Plots across concepts


IncomeStatement
Comprehensive Income Net Of Tax
Expenses
Cost Of Revenue
Balance Sheet
Goodwill
Assets
Other Assets
Current Assets
Accounts Receivable Net Current
NonCurrent Assets
Goodwill
PropertyPlantAndEquipmentNet
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
Liabilities
Operating Lease Liability
Current Liabilities
Accounts Payable Current
Stockholders Equity
Accumulated Other Comprehensive Income Loss Net Of Tax
CashFlow
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInOperatingActivities
Increase Decrease In Accounts Receivable
NetCashProvidedByUsedInInvestingActivities
Net Cash Provided By Used In Investing Activities
Shares
Common Stock Shares Issued
OperatingLeaseLiability
Operating Lease Liability Current
NonoperatingIncomeExpense
Nonoperating Income Expense
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService
(None,)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service